Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 215-662-8 | CAS number: 1338-24-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Remarks:
- Type of genotoxicity: chromosome aberration
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- other: The study is a GLP study and is recently (2010) performed according to standard methods, there it is considered reliable, adequate and relevant.
Cross-reference
- Reason / purpose for cross-reference:
- reference to same study
Data source
Reference
- Reference Type:
- secondary source
- Title:
- Unnamed
- Year:
- 2 010
Materials and methods
Test guidelineopen allclose all
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Deviations:
- yes
- Qualifier:
- according to guideline
- Guideline:
- EPA OPPTS 870.5395 (In Vivo Mammalian Cytogenetics Tests: Erythrocyte Micronucleus Assay)
- Deviations:
- no
- Principles of method if other than guideline:
- The micronucleus test was consistent with the US EPA guidelines for studies of this type (OPPTS 870.5395) and with OECD 474. The testing was in accordance with Good Laboratory Practice Guidelines of the OECD (OECD, 1997) and the U.S. EPA (CFR, 2007). The study was an extension of the combined repeated dose/reproductive and developmental toxicity screening in rats.
Bone marrow was collected from all animals at terminal sacrifice and flushed into a centrifuge tube using a syringe containing heat inactivated fetal bovine serum (HI FBS). The bone marrow was centrifuged, the majority of the HI FBS was decanted, and the pellet was re-suspended. Bone marrow smears were prepared by placing single drops of suspension on microscope slides (minimum of two per preparation). The slides were coded, air dried, fixed in methanol and allowed to air dry a second time.
Coded slides were stained with acridine orange (Hayashi et al., 1983). A total of 1000 erythrocytes/slide were evaluated (both polychromatic (PCE) and normochromatic erythrocytes (NCE)), and the PCE/NCE ratio was calculated. The number of micronucleated PCEs from a total of 2000 PCEs was then determined for each animal.
The percentages of PCEs , micronucleated cells in NCEs, and the ratios of PCEs to total erythrocytes in the test substance- and vehicle-treated groups were compared using ANOV A (Snedecor and Cochran, 1980). If the ANOVA revealed significant (p < 0.05) intergroup variance, Dunnett Test (Dunnett, 1964) was used to compare each test substance-treated group to the vehicle control group. In addition, the positive control and vehicle control groups were compared using a separate parametric one-way ANOVA (Snedecor and Cochran, 1980). - GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Naphthenic acids
- EC Number:
- 215-662-8
- EC Name:
- Naphthenic acids
- Cas Number:
- 1338-24-5
- Molecular formula:
- For the acidic (naphthenic) fraction: CnH2n+zO2, where n = carbon number and z = homologous group series number: z = 0 when no ring structures are present, z = -2 when 1 ring is present, z = -4 when 2 rings are present etc. For the non-acidic fraction: not applicable
- IUPAC Name:
- 11-(decahydronaphthalen-2-yl)undecanoic acid; 11-cyclopentylundecanoic acid; 15-cyclohexylpentadecanoic acid; 3-(tetradecahydroanthracen-2-yl)propanoic acid; 4-(tetradecahydroanthracen-2-yl)butanoic acid; 7-(tetradecahydroanthracen-2-yl)heptanoic acid; 9-(octahydropentalen-2-yl)nonanoic acid; dodecahydro-1H-phenalene-1-carboxylic acid
- Test material form:
- other: liquid
- Details on test material:
- The test sample used in the current program was a blend of naphthenic acids from three sources. The samples were dried under a stream of nitrogen and then re-dissolved in 0.5 mL dichloromethane. The samples were analyzed by GC-MS (Young et al., 2008) and the total ion current mass spectra were collected and tablulated (Holowenko et al., 2002).
Based on these data it was determined that there were no significant differences among these samples (Fedorak, 2009). The data indicated that the test material contained constituents with carbon numbers predominantly in the range of C6-C16 (corresponding to a molecular weight range of approximately 116-250) and with a ring distribution of approximately 0 rings (24%), 1 ring (39%), 2 rings (31%), 3 rings (5%) and 4 rings (1%).
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- no data
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- - Vehicle(s)/solvent(s) used: corn oil
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS: no data
DIET PREPARATION
- Rate of preparation of diet (frequency): no data
- Mixing appropriate amounts with (Type of food): no data
- Storage temperature of food: no data - Duration of treatment / exposure:
Approximately 30 days- Frequency of treatment:
- Daily
- Post exposure period:
- None
Doses / concentrations
- Remarks:
- Doses / Concentrations:
0, 100, 300, 900 mg/kg/day
Basis:
actual ingested
- No. of animals per sex per dose:
- 6 males/6 females
- Control animals:
- yes, concurrent vehicle
- yes, sham-exposed
- Positive control(s):
- cyclophosphamide
- Justification for choice of positive control(s): no data
- Route of administration: oral gavage
- Doses / concentrations: 60 mg/kg/day
Examinations
- Tissues and cell types examined:
- bone marrow , polychromatic and normochromatic eryhtrocytes
- Details of tissue and slide preparation:
- TREATMENT AND SAMPLING TIMES:
Bone marrow was collected from all animals at terminal sacrifice
DETAILS OF SLIDE PREPARATION:
Bone marrow was collected from all animals at terminal sacrifice and flushed into a centrifuge tube using a syringe containing heat inactivated fetal bovine serum (HI FBS). The bone marrow was centrifuged, the majority of the HI FBS was decanted, and the pellet was re-suspended. Bone marrow smears were prepared by placing single drops of suspension on microscope slides (minimum of two per preparation). The slides were coded, air dried, fixed in methanol and allowed to air dry a second time. Coded slides were stained with acridine orange (Hayashi et al., 1983).
METHOD OF ANALYSIS:
A total of 1000 erythrocytes/slide were evaluated (both polychromatic (PCE) and normochromatic erythrocytes (NCE)), and the PCE/NCE ratio was calculated. The number of micronucleated PCEs from a total of 2000 PCEs was then determined for each animal.
The percentages of PCEs , micronucleated cells in NCEs, and the ratios of PCEs to total erythrocytes in the test substance- and vehicle-treated groups were compared using ANOV A (Snedecor and Cochran, 1980). If the ANOVA revealed significant (p < 0.05) intergroup variance, Dunnett Test (Dunnett, 1964) was used to compare each test substance-treated group to the vehicle control group. In addition, the positive control and vehicle control groups were compared using a separate parametric one-way ANOVA (Snedecor and Cochran, 1980). - Statistics:
- The percentages of PCEs , micronucleated cells in NCEs, and the ratios of PCEs to total erythrocytes in the test substance- and vehicle-treated groups were compared using ANOV A (Snedecor and Cochran, 1980). If the ANOVA revealed significant (p < 0.05) intergroup variance, Dunnett Test (Dunnett, 1964) was used to compare each test substance-treated group to the vehicle control group. In addition, the positive control and vehicle control groups were compared using a separate parametric one-way ANOVA (Snedecor and Cochran, 1980).
Results and discussion
Test results
- Sex:
- male/female
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- valid
- Positive controls validity:
- valid
- Additional information on results:
- Systemic toxicity: No treatment-related bone marrow effects.
Genotoxic effects: Not mutagenic. The frequencies of micronuclei in in bone marrow from rats treated with refined naphthenic acids did not differ statistically from those in the sham and vehicle control groups. A significant increase in micronucleus frequency was found in material harvested from rats treated with the positive control, cyclophosphamide providing evidence that the test had worked as expected.
Any other information on results incl. tables
Table 1. Summary of results of micronucleus data from rats following repeated treatment with refined naphthenic acids.
Treatment |
Gender |
Total MN PCEs/2000 PCEs (N=5) |
% MN PCEs |
Total MN NCEs/2000 NCEs (N=5) |
Ratio of PCEs to Total Erythrocytes |
Corn Oil |
Males |
8 |
0.08+0.08 |
3 |
0.54+0.07 |
|
Females |
8 |
0.08+0.12 |
4 |
0.69+0.11 |
|
|
|
|
|
|
Sham Control |
Males |
6 |
0.06+0.04 |
3 |
0.52+0.11 |
|
Females |
8 |
0.08+0.08 |
2 |
0.55+0.17 |
|
|
|
|
|
|
Naphthenic Acid |
|
|
|
|
|
100 mg/kg/day |
Males |
7 |
0.07+0.07 |
1 |
0.53+0.09 |
|
Females |
4 |
0.04+0.04 |
7 |
0.65+0.16 |
300 mg/kg/day |
Males |
4 |
0.04+0.04 |
3 |
0.49+0.67 |
|
Females |
5 |
0.06+0.05 |
5 |
0.67+0.13 |
900 mg/kg/day |
Males |
8 |
0.08+0.08 |
5 |
0.61+0.11 |
|
Females |
5 |
0.06+0.05 |
5 |
0.75+0.19 |
|
|
|
|
|
|
Positive Control (Cyclophosphamide) 60 mg/kg/day |
Males |
128 |
1.28+0.14a |
13 |
0.40+0.21 |
|
Females |
97 |
0.97+0.19a |
16 |
0.51+0.12a |
Applicant's summary and conclusion
- Conclusions:
- Interpretation of results: negative
Naphthenic acids did not induce chromosomal aberrations under the conditions of the test - Executive summary:
A micronucleus test was conducted in male and female Wistar rats with refined Naphtenic acids dosed at 100, 300 and 900 mg/kg bw by oral gavage.A total of 1000 erythrocytes/slide were evaluated (both polychromatic PCE and normochromatic erythrocytes NCE), and the PCE/NCE ratio was calculated. The number of micronucleated PCEs from a total of 2000 PCEs was then determined for each animal.The frequencies of micronuclei in in bone marrow did not differ statistically from those in the sham and vehicle control groups. A significant increase in micronucleus frequency was found in material harvested from rats treated with the positive control, cyclophosphamide providing evidence that the test had worked as expected.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
